7Baggers
 Harvard Bioscience granted 180 days for compliance - SEC filing  MarketScreener Fri, 03 Oct 2025 13:28:25 GMT
 Harvard Bioscience Granted Nasdaq Compliance Extension  TipRanks Fri, 03 Oct 2025 12:30:53 GMT
 published on: 2025-09-17 00:31:47  خودرو بانک Tue, 16 Sep 2025 21:03:47 GMT
 published on: 2025-09-17 01:49:43  خودرو بانک Tue, 16 Sep 2025 16:10:44 GMT
 Harvard Bioscience inks U.S. distribution agreement with Fisher Scientific  Worcester Business Journal Tue, 16 Sep 2025 15:40:47 GMT
 Thermo Fisher (TMO) Enhances U.S. Distribution for Harvard Biosc  GuruFocus Tue, 16 Sep 2025 07:00:00 GMT
 Harvard Bioscience stock price target lowered to $2 at Benchmark  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 Harvard Bioscience Appoints Stephen DeNelsky to Board  The Globe and Mail Wed, 10 Sep 2025 07:00:00 GMT
 Harvard Bioscience, Inc. Appoints Stephen DeNelsky to Board of Directors  Quiver Quantitative Tue, 09 Sep 2025 07:00:00 GMT
 Harvard Bioscience appoints Stephen DeNelsky to board of directors  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 14:54:14  Newser Thu, 04 Sep 2025 08:41:33 GMT
 published on: 2025-08-31 14:54:14  Newser Sun, 31 Aug 2025 19:54:14 GMT
 published on: 2025-09-03 04:16:15  Newser Sun, 31 Aug 2025 19:49:25 GMT
 published on: 2025-08-30 02:12:19  Newser Sat, 30 Aug 2025 07:12:19 GMT
 published on: 2025-08-28 07:59:53  Newser Thu, 28 Aug 2025 12:59:53 GMT

Harvard Bioscience, Inc
(NASDAQ:HBIO) 

HBIO stock logo

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well a...

Full Time Employees: 505
Sector: Healthcare
Industry: Medical Instruments & Supplies

Share this website to your friends